Latest Norris Cotton Cancer Center Stories
Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, and it will appear as a letter in the journal Leukemia, a publication of the prestigious Nature Publishing Group. The study helps address a basic problem of treating CLL. CLL lives both in the blood in circulation, and in lymph nodes and bone marrow. The former is...
SPOKANE, Wash., May 7, 2013 /PRNewswire-USNewswire/ -- Cancer Care Northwest, Kootenai Health and Providence Health Care - the region's premier health care leaders in cancer services - have signed a Memorandum of Understanding to form a new regional cancer alliance aimed at elevating the quality, coordination and care experience for patients and their families throughout the inland northwest. This is not a merger or acquisition. It is an innovative model of clinical collaboration...
WESTMINSTER, Md., April 16, 2013 /PRNewswire-USNewswire/ -- The Joanna M. Nicolay Melanoma Foundation (JMNMF) awarded ten $10,000, nationally competitive, "Research Scholar Awards" (RSA) to exceptional graduate student melanoma researchers at leading cancer centers across the U.S. The JMNMF increased funding again in 2013, to significantly enhance the potential for advancements in the melanoma cancer field; and, to increase the number of young scientists choosing melanoma research as...
LEBANON, N.H., Jan. 22, 2013 /PRNewswire-USNewswire/ -- Prof. Robert A. Oden, Jr. PhD, former president of Carleton College and Kenyon College, has been named Chair of the Dartmouth-Hitchcock Board of Trustees. Oden, a member of the Dartmouth-Hitchcock board since January 2011, succeeded Wayne Granquist as chair on December 31, 2012. "This is an extraordinary time in health care," noted Oden in a message to the Dartmouth-Hitchcock community. "Leading health care organizations have...
KEENE, N.H. and AVENTURA, Fla., Sept. 24, 2012 /PRNewswire/ -- Cheshire Medical Center/Dartmouth-Hitchcock Keene's Linear Accelerator has the highest utilization rate in the state of NH and provides treatment to many cancer patients close to home. Because of the critical importance of this technology and service in our region, a planned replacement to the new Varian TrueBeam(TM) linear accelerator will occur over the next few months. During the changeover, we will have a temporary...
Performing surgery to remove a brain tumor requires surgeons to walk a very fine line. If they leave tumor tissue behind, the tumor is likely to regrow; if they cut out too much normal tissue, they could cause permanent brain damage. "Primary brain tumors look just like brain tissue," says Keith Paulsen, PhD, a professor of biomedical engineering at Thayer School of Engineering and a member of the Cancer Imaging and Radiobiology Research Program at Norris Cotton Cancer Center. "But if...
New Norris Cotton Cancer Center research establishes for first time a cause and effect in adolescent smoking onset according to film rating New research from Norris Cotton Cancer Center estimates, for the first time, the impact of an R rating for movie smoking. James Sargent, MD, co-director of the Cancer Control Research Program at Norris Cotton Cancer Center, emphasizes that an R rating for any film showing smoking could substantially reduce smoking onset in U.S. adolescents -- an effect...
NATIONAL CANCER INSTITUTE DISCONTINUES CANCER INFORMATION SERVICE PARTNERSHIP PROGRAM FREMONT, Calif., Jan. 14 /PRNewswire-USNewswire/ -- As a result of the National Cancer Institute's (NCI) decision to discontinue the Cancer Information Service (CIS) Partnership Program throughout the United States, beginning January 14, 2010, the Northern California Cancer Center (NCCC) will no longer coordinate the program in California. Since 1993, NCCC brought the most recent news and cancer...
At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J. Barth Jr., M.D., and three fellow researchers are making the case for a particular combination of treatments to stop the tumors in their tracks.In the August 2009 issue of the Annals of Surgical Oncology, Barth, an associate professor of surgery at Dartmouth Medical School (DMS), and his colleagues"”among them Wendy Wells, M.D., a professor of pathology at DMS"”recommend using adjuvant...
Dartmouth studies glucorticoid side effectsIn her most recent study of possible triggers of cancer among northern New England residents, Dartmouth epidemiologist Margaret R. Karagas, Ph.D., and her team identified an enhanced risk to the bladders of patients taking drugs that suppress the immune system.The findings, from a population-based, case-control study in New Hampshire, appear in the September 2009 issue of the British Journal of Cancer, with Dartmouth Medical School student Karl...
